Abbott

/Abbott
27 10, 2017

Alere-Abbott to Transform Point of care Market, says Kalorama Report

By |October 27th, 2017|Abbott|Comments Off on Alere-Abbott to Transform Point of care Market, says Kalorama Report

In a recent filing with the US Securities and Exchange Commission, Abbott announced that it has completed the acquisition of Alere, putting an end to the deal that was announced in 2016. Based on the data compiled in 2016, Kalorama Information predicts that Alere-Abbott would be the largest point-of-care diagnostics with nearly a quarter of [...]

27 02, 2017

FDA Grants Approval for Abbott’s Molecular Zika Virus Test

By |February 27th, 2017|Abbott|Comments Off on FDA Grants Approval for Abbott’s Molecular Zika Virus Test

Abbott recently announced that the U.S. FDA has extended Emergency Use Authorization (EUA) for its RealTime ZIKA test to detect Zika virus in whole blood (when collected alongside a patient-matched serum or plasma sample) for emergency use. This is the first molecular test made by a commercial manufacturer authorized to detect Zika in whole blood [...]

15 07, 2015

New Affordable Glucose Testing Solution from Abbott – No Insurance Copayments Needed

By |July 15th, 2015|Abbott|Comments Off on New Affordable Glucose Testing Solution from Abbott – No Insurance Copayments Needed

The American Diabetes Association reports that almost 30 million children and adults in the United States have diabetes. Monitoring blood glucose levels is crucial for diabetic people as it can help avoid serious complications of the disease. Helping to address the rising cost of insurance premiums and employee medical claims in the United States, Abbott, [...]